NCT05624320View on ClinicalTrials.gov

Using AGN-190584 in Subjects Utilizing Single -Use Daily, Contact Lenses

PHASE4WithdrawnINTERVENTIONAL

0

Timeline

Start Date

December 1, 2022

Primary Completion Date

May 30, 2023

Study Completion Date

June 30, 2023

Conditions

Presbyopia

Interventions

DRUG

AGN-190584

miotic for treatment of presbyopia

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AbbVie

INDUSTRY

lead

Gordon Schanzlin New Vision

OTHER